| NCT03187457 |
PreFem: “What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?” |
https://ClinicalTrials.gov/show/NCT03187457 |
Completed |
Danisco |
2017-11-14 |
| NCT03134924 |
Vaginal Practices in Human Immunodeficiency Virus (HIV) Positive Women in Zambia, a Bio-Behavioral Intervention “WASH-2” |
https://ClinicalTrials.gov/show/NCT03134924 |
Completed |
University of Miami |
2014-02-05 |
| NCT03116789 |
Analysis of Ameliorative Effects of Oral Probiotics on Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT03116789 |
Completed |
GenMont Biotech Incorporation |
2019-12-31 |
| NCT03099408 |
Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT03099408 |
Recruiting |
Peking University Shenzhen Hospital |
2020-12-30 |
| NCT03091777 |
Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT03091777 |
Completed |
Gage Development Company, LLC |
2017-11-15 |
| NCT02946346 |
Kinetics and Ecology of Human Papillomavirus Genital Infections in Young Women |
https://ClinicalTrials.gov/show/NCT02946346 |
Recruiting |
University Hospital, Montpellier |
2021-09-30 |
| NCT02905890 |
The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT02905890 |
Completed |
London School of Hygiene and Tropical Medicine |
2019-12-20 |
| NCT02866227 |
TOL-463 Phase 2 Study for Vaginitis |
https://ClinicalTrials.gov/show/NCT02866227 |
Completed |
Toltec Pharmaceuticals, LLC |
2017-06-10 |
| NCT02863536 |
A Study of the New Medical Device Polybactum® |
https://ClinicalTrials.gov/show/NCT02863536 |
Completed |
Effik Italia S.p.A. |
2018-08-01 |
| NCT02860845 |
Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections |
https://ClinicalTrials.gov/show/NCT02860845 |
Completed |
Laboratorios Ordesa |
2017-10-16 |
| NCT02795845 |
Oral Probiotics for the Treatment and Prevention of Vulvovaginal Infections in Pregnancy - Double-blind, Randomized, Placebo-controlled Study |
https://ClinicalTrials.gov/show/NCT02795845 |
Recruiting |
HaEmek Medical Center, Israel |
2021-07-31 |
| NCT02766023 |
LACTIN-V Study for Recurrent Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT02766023 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2019-02-11 |
| NCT02744638 |
Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains on Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT02744638 |
Completed |
Clinical Research Center Kiel GmbH |
2016-08-31 |
| NCT02709005 |
Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT02709005 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2017-12-11 |
| NCT02687789 |
Safety, Tolerability and Efficacy of Vaginal Suppository WO3191 in the Post-treatment of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT02687789 |
Completed |
Dr. August Wolff GmbH & Co. KG Arzneimittel |
2015-07-31 |
| NCT02042287 |
Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT02042287 |
Recruiting |
University Hospital Inselspital, Berne |
2021-12-31 |
| NCT02527941 |
Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology |
https://ClinicalTrials.gov/show/NCT02527941 |
Completed |
University of Toronto |
2015-11-30 |
| NCT02459665 |
Rwanda Vaginal Microbiota Restoration Study |
https://ClinicalTrials.gov/show/NCT02459665 |
Completed |
University of Liverpool |
2016-02-23 |
| NCT02452866 |
Open-Label Study to Evaluate the Safety of A Single Dose of SYM-1219, a Granule Formulation Containing 2 Grams of Secnidazole |
https://ClinicalTrials.gov/show/NCT02452866 |
Completed |
Symbiomix Therapeutics |
2015-10-31 |
| NCT02445989 |
Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity |
https://ClinicalTrials.gov/show/NCT02445989 |
Completed |
University of Washington |
2018-11-30 |
| NCT02432404 |
Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity |
https://ClinicalTrials.gov/show/NCT02432404 |
Active, not recruiting |
University of Washington |
2020-07-31 |
| NCT02418845 |
A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT02418845 |
Completed |
Symbiomix Therapeutics |
2015-10-31 |
| NCT02392026 |
Safety and Tolerability of Metronidazole Gel 1.3% |
https://ClinicalTrials.gov/show/NCT02392026 |
Completed |
Insud Pharma |
2016-10-31 |
| NCT02314429 |
Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT02314429 |
Completed |
University Hospital, Ghent |
2015-01-31 |
| NCT02237950 |
Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) |
https://ClinicalTrials.gov/show/NCT02237950 |
Completed |
Starpharma Pty Ltd |
2016-12-09 |
| NCT02236429 |
Vaginal Flora for Treatment of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT02236429 |
Recruiting |
Hadassah Medical Organization |
2020-03-31 |
| NCT02236156 |
Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) |
https://ClinicalTrials.gov/show/NCT02236156 |
Completed |
Starpharma Pty Ltd |
2016-07-04 |
| NCT02210689 |
A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women |
https://ClinicalTrials.gov/show/NCT02210689 |
Completed |
Actavis Inc. |
2014-10-31 |
| NCT02209519 |
Randomized Controlled Trial of Treatment of Male Partners of Women With BV |
https://ClinicalTrials.gov/show/NCT02209519 |
Completed |
University of Alabama at Birmingham |
2019-03-31 |
| NCT02150655 |
Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women |
https://ClinicalTrials.gov/show/NCT02150655 |
Completed |
Western University, Canada |
2013-09-30 |
| NCT02147899 |
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT02147899 |
Completed |
Symbiomix Therapeutics |
2014-10-31 |
| NCT02139839 |
Exploratory Study to Evaluate the Effects of the Probiotics L. Rhamnosus GR-1 and L. Reuteri RC-14 |
https://ClinicalTrials.gov/show/NCT02139839 |
Completed |
Kimberly-Clark Corporation |
2013-03-31 |
| NCT01293643 |
A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077) |
https://ClinicalTrials.gov/show/NCT01293643 |
Completed |
Merck Sharp & Dohme Corp. |
2011-01-31 |
| NCT01993524 |
Supplementation of Standard Antibiotic Therapy With Oral Probiotics for Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT01993524 |
Completed |
IBSS Biomed S.A. |
2012-02-29 |
| NCT01800825 |
Clindamycin to Reduce Preterm Birth in a Low Resource Setting |
https://ClinicalTrials.gov/show/NCT01800825 |
Completed |
Christiana Care Health Services |
2016-04-30 |
| NCT01697683 |
Probiotic Therapy for the Reversal of Bacterial Vaginosis in Pregnancy |
https://ClinicalTrials.gov/show/NCT01697683 |
Completed |
Mount Sinai Hospital, Canada |
2014-03-31 |
| NCT01621399 |
Safety and Efficacy Study to Treat Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT01621399 |
Completed |
Medicis Global Service Corporation |
2012-10-31 |
| NCT01577537 |
A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT01577537 |
Completed |
Starpharma Pty Ltd |
2012-10-05 |
| NCT01577238 |
A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT01577238 |
Completed |
Starpharma Pty Ltd |
2012-07-20 |
| NCT01471457 |
Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT01471457 |
Completed |
University of New Mexico |
2014-09-30 |
| NCT01450462 |
Vitamin D and Sexual Health |
https://ClinicalTrials.gov/show/NCT01450462 |
Completed |
Ohio State University |
2013-01-31 |
| NCT01437722 |
Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV) |
https://ClinicalTrials.gov/show/NCT01437722 |
Completed |
Starpharma Pty Ltd |
2012-12-31 |
| NCT01347632 |
Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal Tissue |
https://ClinicalTrials.gov/show/NCT01347632 |
Completed |
CONRAD |
2011-12-31 |
| NCT04329338 |
Effects of Lactobacillus Pentosus KCA1 on the Gut and Vaginal Microbiome of Women With Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT04329338 |
Completed |
Nnamdi Azikiwe University |
2019-09-20 |
| NCT04189744 |
The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract |
https://ClinicalTrials.gov/show/NCT04189744 |
Recruiting |
London School of Hygiene and Tropical Medicine |
2022-05-06 |
| NCT04171947 |
Vaginal Ovule With Flavonoid Tea Extract for the Correction of Imbalance in the Vaginal Environment |
https://ClinicalTrials.gov/show/NCT04171947 |
Completed |
Value Outcomes Ltd. |
2018-05-09 |
| NCT04046900 |
Modifying Organisms Transvaginally in Females |
https://ClinicalTrials.gov/show/NCT04046900 |
Recruiting |
Massachusetts General Hospital |
2021-07-31 |
| NCT03954990 |
Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity |
https://ClinicalTrials.gov/show/NCT03954990 |
Recruiting |
The University of Texas Medical Branch, Galveston |
2021-06-01 |
| NCT03943823 |
Postmenopausal Pessary Users: Estrogen Versus Trimosan |
https://ClinicalTrials.gov/show/NCT03943823 |
Recruiting |
The University of Texas Health Science Center, Houston |
2022-05-01 |
| NCT03937869 |
Evaluate the Safety of a Single Oral Dose of Solosecâ„¢ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV |
https://ClinicalTrials.gov/show/NCT03937869 |
Recruiting |
Lupin Research Inc |
2020-12-31 |
| NCT03930745 |
Suppression Of Bacterial Vaginosis (BV) [SUBVert] |
https://ClinicalTrials.gov/show/NCT03930745 |
Recruiting |
National Institute of Allergy and Infectious Diseases (NIAID) |
2020-07-01 |
| NCT03894813 |
Probiotics as Adjuvant Treatment for Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT03894813 |
Recruiting |
Peking University Shenzhen Hospital |
2020-12-30 |
| NCT03878511 |
Therapeutic Lactose to Support Vaginal Microbiota |
https://ClinicalTrials.gov/show/NCT03878511 |
Completed |
Regionshospitalet Viborg, Skive |
2013-03-01 |
| NCT03839875 |
Evaluation of Efficacy and Safety of Gynomax® XL Ovule |
https://ClinicalTrials.gov/show/NCT03839875 |
Completed |
Exeltis Turkey |
2019-08-09 |
| NCT03837015 |
Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women |
https://ClinicalTrials.gov/show/NCT03837015 |
Recruiting |
McMaster University |
2020-12-31 |
| NCT03762083 |
Clinical Performance of a Vaginal Pessary (pHyph) in Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT03762083 |
Completed |
Gedea Biotech AB |
2019-10-22 |
| NCT03601429 |
Dietary Supplementation of Lactogyn in Women With Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT03601429 |
Completed |
Vesale Pharmaceutica |
2018-08-31 |
| NCT03446443 |
Honghe Fujie Lotion for the Treatment of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT03446443 |
Recruiting |
Dongfang Hospital Beijing University of Chinese Medicine |
2019-07-31 |
| NCT01258556 |
The Impact of Probiotic Bacteria on the Efficacy of Anti-retroviral Therapy and Recurrence of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT01258556 |
Completed |
Lawson Health Research Institute |
2010-07-31 |
| NCT01245322 |
Treatment of Bacterial Vaginosis Combined With Human Lactobacilli |
https://ClinicalTrials.gov/show/NCT01245322 |
Completed |
Skaraborg Hospital |
2014-10-31 |
| NCT01230814 |
Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women |
https://ClinicalTrials.gov/show/NCT01230814 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-08-31 |
| NCT01201057 |
Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV) |
https://ClinicalTrials.gov/show/NCT01201057 |
Completed |
Starpharma Pty Ltd |
2011-03-31 |
| NCT01160796 |
Lcr35® for Bacterial Vaginosis Prevention |
https://ClinicalTrials.gov/show/NCT01160796 |
Completed |
Laboratoires Lyocentre |
2011-05-31 |
| NCT01125410 |
Comparative Study of Efficacy of 10 mg Dequalinium Chloride (Fluomizin) in the Local Treatment of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT01125410 |
Completed |
Medinova AG |
2008-07-31 |
| NCT01055106 |
Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT01055106 |
Completed |
Graceway Pharmaceuticals, LLC |
2010-04-30 |
| NCT01020396 |
Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT01020396 |
Completed |
Teva Pharmaceuticals USA |
2003-03-31 |
| NCT04414527 |
Effects of Video-based Health Education on Maternal and Child Health in Ethiopia |
https://ClinicalTrials.gov/show/NCT04414527 |
Recruiting |
University Ghent |
2021-12-31 |
| NCT02641717 |
Validity of Patient-Collected Wet Mounts |
https://ClinicalTrials.gov/show/NCT02641717 |
Completed |
The University of Texas Health Science Center at San Antonio |
2016-07-31 |
| NCT03211156 |
Treatment of Gardnerella Vaginalis Vaginal Colonization With Amoxicillin |
https://ClinicalTrials.gov/show/NCT03211156 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2019-08-22 |
| NCT00720291 |
Inflammation and Treatment of Bacterial Vaginosis Near Term |
https://ClinicalTrials.gov/show/NCT00720291 |
Completed |
Medical University of South Carolina |
2010-11-23 |
| NCT00667368 |
Bacterial Vaginosis Home Screening to Prevent STDs |
https://ClinicalTrials.gov/show/NCT00667368 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2014-12-31 |
| NCT00642980 |
Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT00642980 |
Completed |
University Hospital, Lille |
2011-06-30 |
| NCT00635622 |
Safety and Efficacy Study of Lactobacillus Administered Vaginally in Women With Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT00635622 |
Completed |
Osel, Inc. |
2009-01-31 |
| NCT00556179 |
Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT00556179 |
Completed |
Sanofi |
2008-12-31 |
| NCT00545181 |
Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial |
https://ClinicalTrials.gov/show/NCT00545181 |
Completed |
Indiana University |
2009-07-31 |
| NCT00542074 |
Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence |
https://ClinicalTrials.gov/show/NCT00542074 |
Completed |
University of Washington |
NA |
| NCT00537576 |
Safety Study of Lactobacillus Administered Vaginally to Healthy Women |
https://ClinicalTrials.gov/show/NCT00537576 |
Completed |
Osel, Inc. |
2008-03-31 |
| NCT00510614 |
Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study |
https://ClinicalTrials.gov/show/NCT00510614 |
Completed |
University of Pittsburgh |
2009-09-30 |
| NCT00484653 |
Identification and Impact of Vaginal Flora Anomalies Among Pregnant Woman |
https://ClinicalTrials.gov/show/NCT00484653 |
Completed |
Assistance Publique Hopitaux De Marseille |
2013-07-31 |
| NCT00464542 |
Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study |
https://ClinicalTrials.gov/show/NCT00464542 |
Completed |
University of Pittsburgh |
2010-03-31 |
| NCT00799500 |
Bacterial Vaginosis in Pregnancy: Detection by Weekly Vaginal pH Testing |
https://ClinicalTrials.gov/show/NCT00799500 |
Completed |
Hospital Clinic of Barcelona |
2010-12-31 |
| NCT00334633 |
Treatment of Bacterial Vaginosis (BV) With Tinidazole |
https://ClinicalTrials.gov/show/NCT00334633 |
Completed |
University of Alabama at Birmingham |
2009-12-31 |
| NCT00324818 |
Treatment of Bacterial Vaginosis |
https://ClinicalTrials.gov/show/NCT00324818 |
Completed |
University of Alabama at Birmingham |
2006-05-31 |
| NCT00318253 |
The Effects of Cranberry Juice on Bacterial Adhesion |
https://ClinicalTrials.gov/show/NCT00318253 |
Completed |
Lawson Health Research Institute |
2006-08-31 |
| NCT00313131 |
Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments |
https://ClinicalTrials.gov/show/NCT00313131 |
Completed |
Université de Sherbrooke |
NA |
| NCT00799214 |
BASIC (Boric Acid, Alternate Solution for Intravaginal Colonization) Study |
https://ClinicalTrials.gov/show/NCT00799214 |
Completed |
University of British Columbia |
2015-11-30 |
| NCT00229216 |
Treatment of Bacterial Vaginosis With Oral Tinidazole |
https://ClinicalTrials.gov/show/NCT00229216 |
Completed |
Mission Pharmacal |
2007-06-30 |
| NCT00140764 |
Intravaginal Treatment of Disturbances of Vaginal Flora Among HIV Infected and Uninfected Women in Malawi |
https://ClinicalTrials.gov/show/NCT00140764 |
Completed |
Johns Hopkins Bloomberg School of Public Health |
NA |
| NCT00153517 |
Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy |
https://ClinicalTrials.gov/show/NCT00153517 |
Completed |
Centers for Disease Control and Prevention |
NA |